Evidence map›Paper›PMID 38338432›Full record

ReviewMolecules (Basel, Switzerland)2024

Rare Earths-The Answer to Everything.

Thomas Behrsing, Victoria L Blair, Florian Jaroschik, Glen B Deacon, Peter C Junk

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Direct Reuse of Spent Nd-Fe-B Permanent Magnets.Materials (Basel, Switzerland) · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Thomas BehrsingSchool of Chemistry, Monash University, Melbourne, VIC 3800, Australia.
Victoria L BlairSchool of Chemistry, Monash University, Melbourne, VIC 3800, Australia.
Florian JaroschikICGM, Univ Montpellier, CNRS, ENSCM, 34090 Montpellier, France.ORCID 0000-0003-0201-568X
Glen B DeaconSchool of Chemistry, Monash University, Melbourne, VIC 3800, Australia.ORCID 0000-0002-6966-6121
Peter C JunkCollege of Science & Engineering, James Cook University, Townsville, QLD 4811, Australia.ORCID 0000-0002-0683-8918
Monash University · AUÉcole Nationale Supérieure de Chimie de Montpellier · FRJames Cook University · AU

Funding

Australian Research Council DP230100112
6 · The paper itself

Abstract

Rare earths, scandium, yttrium, and the fifteen lanthanoids from lanthanum to lutetium, are classified as critical metals because of their ubiquity in daily life. They are present in magnets in cars, especially electric cars; green electricity generating systems and computers; in steel manufacturing; in glass and light emission materials especially for safety lighting and lasers; in exhaust emission catalysts and supports; catalysts in artificial rubber production; in agriculture and animal husbandry; in health and especially cancer diagnosis and treatment; and in a variety of materials and electronic products essential to modern living. They have the potential to replace toxic chromates for corrosion inhibition, in magnetic refrigeration, a variety of new materials, and their role in agriculture may expand. This review examines their role in sustainability, the environment, recycling, corrosion inhibition, crop production, animal feedstocks, catalysis, health, and materials, as well as considering future uses.

Indexed as

agriculturecatalysiscorrosion inhibitorsenvironmenthealthmaterialsrare earthsrecyclingsustainability

Identifiers

PMID38338432
PMCPMC10856286
OpenAlexW4391450819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.